Next 10 |
home / stock / ecl / ecl articles
The Invesco Water Resources ETF (NASDAQ: PHO) was launched on 12/06/2005, and is a smart beta exchange traded fund designed to offer broad exposure...
DuPont de Nemours Inc. (NYSE: DD) announced that its Tyvek production facility at the Spruance manufacturing plant in Richmond has achieved certifi...
Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.37% on an annualized basis producing an average annual return of 10.77%. ...
Shares of Baxter International (NYSE: BAX) have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation S...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
DexCom Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE: ABT) are likely to launch their first over-the-counter (OTC) continuous glucose moni...
Glaukos Corporation (NYSE: GKOS) is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, ...
GE Healthcare Technologies, Inc. (NASDAQ: GEHC), in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children's,...
L'Air Liquide S.A (OTC: AIQUY) has initiated a new Group transformation initiative to foster agility and improve efficiency using its ADVANCE s...
News, Short Squeeze, Breakout and More Instantly...
DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities. BioProcess360 Partners...
Ecolab Inc. (NYSE: ECL) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.2% on the day to $243.43. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internatio...
2024-07-08 06:00:05 ET Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $283.00 for ECL on 2024-07-08 05:06:00. The adjusted price target was set to $283.00. At the time of the announcement, ECL was trading at $238.19. The overall price target consensus is ...